N/A
N=445
Improving Colonoscopy Quality for Colorectal Cancer Screening in the National VA Healthcare System
Colorectal Neoplasms
Bottom Line
View on ClinicalTrials.gov: NCT04389957 ↗Enrolled (actual)
445
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Provider Adenoma Detection Rate (for All Colonoscopies) — 52.7; 46.9; 43.5; 42.8 % of colonoscopies w/ 1+ adenomas
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Veterans Affairs Endoscopy Quality Improvement Program (VA-EQuIP) (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Mar 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Provider Adenoma Detection Rate (for All Colonoscopies) |
52.7; 46.9; 43.5; 42.8; 45.6; 50.9 | — |
| SECONDARY Bowel Preparation Quality (Provider Level) |
19; 21; 48; 50; 44; 65 | — |
| SECONDARY Cecal Intubation Rate (Provider Level) - Revision |
16; 22; 41; 51; 31; 68 | — |
Summary
High quality screening colonoscopy is critical for colorectal cancer (CRC) prevention in Veterans. There is significant variability in colonoscopy quality in VA that is directly linked to differences in CRC incidence and death. The investigators developed the VA Endoscopy Quality Improvement Program (VA-EQuIP) that the National GI program office will implement using centralized quality measurement and reporting for adenoma detection rates (ADR), bi-annual audit and feedback with provider benchmarking to local and national performance, and collaborative learning to support colonoscopy quality improvement. Using a cluster randomized controlled trial, the investigators will study the implementation of VA-EQuIP and determine the efficacy of its intervention on adenoma detection rates, which are directly linked to CRC incidence and death.
Eligibility Criteria
Inclusion Criteria
- Quantitative surveys will be delivered to endoscopy or GI section chiefs responsible for endoscopy services for each enrolled site.
- Qualitative interviews will be conducted with GI section chiefs and individual endoscopists at participating facilities.
- A list of criteria for selection of participants in the clinical study, provided in terms of inclusion and exclusion criteria is suitable for assisting potential participants in identifying clinical studies of interest.
- All VA facilities with existing colonoscopy procedure or pathology notes in our operational database.
Exclusion Criteria
-VA facilities without existing colonoscopy procedure or pathology notes in our operational database will not be included in the study.
Data sourced from ClinicalTrials.gov (NCT04389957). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.